IMA Advisory Services’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Other funds holding IONS
IMA Advisory Services's IONS Position: Q2 2026 in Review
IMA Advisory Services increased its Ionis Pharmaceuticals (IONS) stake by 3,604% in Q2 2026, buying an estimated $75.9K and bringing the position to 1,037 shares worth $82.2K. The position accounts for 0.01% of the portfolio, ranked #446.
IMA Advisory Services first reported a position in IONS in Q2 2025 and has held it in 5 quarters since. 515 funds tracked by Wall St. Rank hold IONS as of Q2 2026.
- IMA Advisory Services held 1,037 shares of Ionis Pharmaceuticals worth $82.2K as of Q2 2026.
- IMA Advisory Services bought 1,009 Ionis Pharmaceuticals shares in Q2 2026, an estimated $75.9K.
- Ionis Pharmaceuticals made up 0.01% of IMA Advisory Services's portfolio in Q2 2026, its #446 holding.
- IMA Advisory Services first reported a position in Ionis Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
- 515 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.
Based on IMA Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.